Stifel analyst Justin Keywood lowered the firm’s price target on Healwell AI (HWAIF) to C$3.10 from C$3.80 and keeps a Buy rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HWAIF:
- HEALWELL AI Expands DARWEN Platform’s Scientific Footprint With 47 Peer-Reviewed Studies
- HEALWELL AI Sets March Dates to Release 2025 Results and Brief Investors
- HEALWELL AI Wins Major U.S. HIE Deal as AI-Enabled Platform Gains Global Traction
- HEALWELL AI Steps Up Investor Outreach With March Conference Lineup
- HEALWELL AI: Scaling Government-Grade Healthcare AI With Recurring SaaS and Strategic Cross-Sell Synergies